Does Oxycodone Cause Bradycardia?
Yes, oxycodone can cause bradycardia, particularly in overdose situations, though it occurs less frequently than other opioid-related adverse effects.
Evidence from FDA Drug Labeling
The FDA-approved prescribing information for oxycodone explicitly lists bradycardia as a documented adverse effect. In overdose scenarios, bradycardia is specifically mentioned alongside other serious manifestations including respiratory depression, hypotension, and coma 1. The drug label also warns that oxycodone may cause severe hypotension and circulatory depression, which can be accompanied by bradycardia 1.
Clinical Evidence and Frequency
Overdose Settings
In a retrospective study of 137 oxycodone overdoses, 18% of patients developed bradycardia, with 5 patients experiencing heart rates below 50 beats per minute 2. This study demonstrated that bradycardia is a recognized complication of oxycodone toxicity, occurring more commonly with sustained-release formulations.
Therapeutic Doses
At standard analgesic doses, bradycardia is less common but documented. Opioids including oxycodone can lead to bradycardia through vasodilation and direct cardiovascular effects 3. A 2024 real-world pharmacovigilance study analyzing the FDA Adverse Event Reporting System confirmed bradycardia as a significant adverse drug reaction associated with strong opioids including oxycodone 4.
Mechanism
Oxycodone exerts its bradycardic effects through:
- Opening of potassium channels and closing of calcium channels, decreasing synaptic transmission 5
- Vasodilation leading to decreased cardiac output 1
- Direct effects on cardiac conduction, though less pronounced than with methadone 6, 7
Risk Factors for Bradycardia
Higher risk patients include:
- Those taking sustained-release formulations (greater naloxone requirements and longer duration of effects) 2
- Patients on concomitant medications, particularly phenytoin or other CNS depressants 5
- Overdose situations with doses significantly exceeding therapeutic ranges 2
- Elderly, cachectic, or debilitated patients with altered pharmacokinetics 1
Clinical Management
If bradycardia develops with oxycodone:
- Assess hemodynamic stability - determine if the bradycardia is causing symptoms or compromise
- Administer naloxone if respiratory depression or circulatory compromise is present - bradycardia from oxycodone overdose is naloxone-responsive 2
- Consider atropine 0.5-1 mg IV for symptomatic bradycardia per ACC/AHA guidelines, though the 1.0 mg dose shows superior first-dose success rates 8, 9
- Monitor ECG - while oxycodone is considered intermediate-risk for QT prolongation, ECG abnormalities occurred in 72.5% of acute toxicity cases 6, 10
Important Caveats
- Bradycardia is less common than respiratory depression, which remains the primary life-threatening effect of opioid toxicity 1
- Unlike methadone, oxycodone is classified as intermediate-risk for cardiac arrhythmias, causing problems primarily at high doses 6, 7
- Sinus bradycardia (51%) was the most common ECG finding in opioid toxicity cases, more frequent than other rhythm disturbances 2
- The combination of oxycodone with benzodiazepines or other CNS depressants significantly increases cardiovascular risk 1
The bottom line: While not the most common adverse effect, bradycardia is a documented and clinically significant complication of oxycodone use, particularly in overdose or when combined with other medications. Monitoring and naloxone availability are essential.